These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 715539)

  • 1. [Fibrinogen degradatiopnroducts in the serum and urine in chronic nephritis].
    Kutyrina IM; Muzychenko LI; Nevraeva OG; Kriachko AA; Tareeva IE
    Sov Med; 1978 Oct; (10):68-75. PubMed ID: 715539
    [No Abstract]   [Full Text] [Related]  

  • 2. [Blood serum and urine levels of fibrin fibrinogen degradation products in kidney diseases].
    Kacprzyk F; Orłowski Z
    Pol Tyg Lek; 1980 Mar; 35(13):461-3. PubMed ID: 7393746
    [No Abstract]   [Full Text] [Related]  

  • 3. [Fibrin fibrinogen degradation products in the urine and blood in patients with diabetes mellitus and renal complications].
    Astrug A; Shipkova P
    Vutr Boles; 1982; 21(5):81-8. PubMed ID: 7164412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urinary fibrin split products in lupus nephritis.
    Zizic TM; Cwazka WF; Young NS; Stevens MB
    J Rheumatol; 1976 Mar; 3(1):43-9. PubMed ID: 775087
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Fibrin fibrinogen degradation products and their significance in kidney diseases (literature review)].
    Peleshchuk AP; Belitskaia GA; Ena IaM; Drannik GN
    Vrach Delo; 1979 Aug; (8):1-5. PubMed ID: 384672
    [No Abstract]   [Full Text] [Related]  

  • 6. Renal vein fibrin degradation products (FDP's) in glomerulonephritis.
    Tomura S; Ideura T; Ida T; Osaka Y; Kuriyama R; Abe T; Takeuchi J
    Clin Nephrol; 1979 Dec; 12(6):248-53. PubMed ID: 527278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma fibrinogen, fibrinolytic activity and serum fibrinogen/fibrin degradation products in ischaemic heart disease.
    Dube B; Somani PN; Tripathi GK; Dube RK; Bhattacharya SK
    J Assoc Physicians India; 1985 Dec; 33(12):784-5, 787. PubMed ID: 3837002
    [No Abstract]   [Full Text] [Related]  

  • 8. Fibrin-fibrinogen degradation products in children with renal disease.
    Ambrus JL; Baliah T; Ambrus CM; Mink IB; Murphy GP
    N Y State J Med; 1974 Jul; 74(8):1396-402. PubMed ID: 4277485
    [No Abstract]   [Full Text] [Related]  

  • 9. [On coagulation and fibrinolysis in renal diseases, with special reference to FDP subfragment and urinary plasmin body].
    Nakamichi S
    Nihon Jinzo Gakkai Shi; 1984 Apr; 26(4):353-66. PubMed ID: 6236317
    [No Abstract]   [Full Text] [Related]  

  • 10. [Calcium balance in chronic renal insufficiency].
    Graziani G; Della Grazia M; Imbasciati E; Ponticelli C; Redaelli B
    Minerva Nefrol; 1967; 14(3):125-9. PubMed ID: 5596513
    [No Abstract]   [Full Text] [Related]  

  • 11. [Immunoenzyme determination of fibrinogen and its degradation products in kidney diseases].
    Maĭdannik VG
    Vrach Delo; 1989 May; (5):75-7. PubMed ID: 2672585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Osmolarity and plasmatic tonicity and their regulation in chronic renal insufficiency].
    Cioni L; Balestri PL; Giovannetti S
    Minerva Nefrol; 1966; 13(2):55-8. PubMed ID: 5960309
    [No Abstract]   [Full Text] [Related]  

  • 13. [Hormones regulating phosphorus-calcium metabolism in patients with systemic lupus erythematosus nephritis and Bright disease].
    Strunin SE; Nikiforova NV; Ermolenko VM; Mozzhechkov VT; Doroguntseva IN
    Klin Med (Mosk); 1985 Jun; 63(6):61-4. PubMed ID: 4033031
    [No Abstract]   [Full Text] [Related]  

  • 14. [Blood coagulation and glomerular nephritis].
    Hatano M; Kaizu K
    Nihon Rinsho; 1981; 39(12):3674-9. PubMed ID: 7339027
    [No Abstract]   [Full Text] [Related]  

  • 15. A study of soluble fibrin monomer complexes (SFMC) and plasma fibrinogen in acute myocardial infarction.
    Jain SM; Trivedi S
    Indian J Chest Dis Allied Sci; 1984; 26(2):98-103. PubMed ID: 6530267
    [No Abstract]   [Full Text] [Related]  

  • 16. [The beta 2-microglobulin content of the blood serum and urine in patients with primary chronic and lupus glomerulonephritis].
    Diadyk AI; Siniachenko OV; Shtoda LA; Siniachenko TIu; Khomenko MV; Iarovaia NF; Zviagina TV
    Vrach Delo; 1991 Sep; (9):61-4. PubMed ID: 1759435
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Change in lipid metabolism in certain kidney diseases].
    Shul'tsev GP; Mutina ES
    Ter Arkh; 1969 Apr; 41(4):35-42. PubMed ID: 5379409
    [No Abstract]   [Full Text] [Related]  

  • 18. [Fibrin fibrinogen degradation products in the blood in systemic lupus erythematosus and other major collagen diseases].
    Wysocka K; Kiczak J
    Reumatologia; 1982; 20(1-2):15-21. PubMed ID: 7163659
    [No Abstract]   [Full Text] [Related]  

  • 19. Urinary fibrin-fibrinogen degradation products and intraglomerular fibrin-fibrinogen deposition in various renal diseases.
    Kamitsuji H; Tani K; Taniguchi A; Masuyama H; Iida Y; Fukui H
    Thromb Res; 1981 Feb; 21(3):285-94. PubMed ID: 7245140
    [No Abstract]   [Full Text] [Related]  

  • 20. [Clinical significance of fibrin/fibrinogen degradation products in primary glomerular disease (author's transl)].
    Kazuta Y
    Nihon Jinzo Gakkai Shi; 1978 Apr; 20(4):383-95. PubMed ID: 671857
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.